Early Tacrolimus Concentrations After Lung Transplant Are Predicted by Combined Clinical and Genetic Factors and Associated With Acute Kidney Injury.

MLA

Miano, Todd A., et al. “Early Tacrolimus Concentrations After Lung Transplant Are Predicted by Combined Clinical and Genetic Factors and Associated With Acute Kidney Injury.” Clinical Pharmacology and Therapeutics, vol. 107, no. 2, Feb. 2020, pp. 462–70. EBSCOhost, https://doi.org/10.1002/cpt.1629.

APA

Miano, T. A., Flesch, J. D., Feng, R., Forker, C. M., Brown, M., Oyster, M., Kalman, L., Rushefski, M., Cantu, E., 3rd, Porteus, M., Yang, W., Localio, A. R., Diamond, J. M., Christie, J. D., & Shashaty, M. G. S. (2020). Early Tacrolimus Concentrations After Lung Transplant Are Predicted by Combined Clinical and Genetic Factors and Associated With Acute Kidney Injury. Clinical Pharmacology and Therapeutics, 107(2), 462–470. https://doi.org/10.1002/cpt.1629

Chicago

Miano, Todd A, Judd D Flesch, Rui Feng, Caitlin M Forker, Melanie Brown, Michelle Oyster, Laurel Kalman, et al. 2020. “Early Tacrolimus Concentrations After Lung Transplant Are Predicted by Combined Clinical and Genetic Factors and Associated With Acute Kidney Injury.” Clinical Pharmacology and Therapeutics 107 (2): 462–70. doi:10.1002/cpt.1629.